Literature DB >> 15472314

Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis.

Justus G Garweg1, Silvia-Daniela L Garweg, Franziska Flueckiger, Patrick Jacquier, Matthias Boehnke.   

Abstract

The purpose of this study was to compare the local and systemic Toxoplasma-specific humoral immune responses in individuals with ocular toxoplasmosis (OT). To this end, paired aqueous humor and serum samples from 46 individuals with active OT and from 30 individuals without inflammatory eye disease (controls) were analyzed by immunoblotting for anti-Toxoplasma immunoglobulin G (IgG), IgA, IgM, and IgE directed against 20- to 120-kDa antigens. The presence in the aqueous humor of a unique band, or of at least three bands that were at least three times more intense in aqueous humor than in serum, was taken as evidence of local antibody production. IgG bands were detected in 98% of the aqueous humor samples, while IgA bands were detected in 76%, IgM bands were detected in 8%, and IgE bands were not detected in any. Evidence of local production of specific antibodies was found in 32 cases (70%) (IgG in 23 [50%]; IgA in 16 [35%]). In 10 instances (22%), routine laboratory tests were not indicative of OT. In 14 cases (30%), no local antibody production was detected by immunoblotting; 3 of these cases yielded evidence of local antibody production according to the Goldmann-Witmer coefficient. Local antibody production was revealed for 7 of the 30 controls (23%). Hence, the sensitivity of immunoblotting for IgG and IgA is 70%, and the specificity is 77%. We conclude that immunoblotting for local specific IgG and IgA supports the clinical diagnosis of OT in 70% of cases. In 22% of these, the diagnosis is not confirmed by other laboratory tests. Hence, immunoblotting increases the sensitivity of routine laboratory tests and should be considered for samples that register negative by such tests.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472314      PMCID: PMC522375          DOI: 10.1128/JCM.42.10.4593-4598.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  IgA antibodies to Toxoplasma gondii in human tears.

Authors:  B Meek; V N Klaren; N J van Haeringen; A Kijlstra; R Peek
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Human antiretinal antibodies in toxoplasma retinochoroiditis.

Authors:  R M Whittle; G R Wallace; R A Whiston; D C Dumonde; M R Stanford
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

3.  Anti-Toxoplasma gondii immunoglobulins A and G in human saliva and serum.

Authors:  A M Loyola; A F Durighetto; D A Silva; J R Mineo
Journal:  J Oral Pathol Med       Date:  1997-04       Impact factor: 4.253

4.  Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens.

Authors:  R B Nussenblatt; K K Mittal; S Fuhrman; S D Sharma; A G Palestine
Journal:  Am J Ophthalmol       Date:  1989-06-15       Impact factor: 5.258

5.  Laboratory tests in uveitis. New developments in the analysis of local antibody production.

Authors:  A Kijlstra; G J van den Horn; L Luyendijk; G S Baarsma; C M Schweitzer; M J Zaal; Z Timmerman; M Beintema; A Rothova
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

6.  Immunoblotting can help the diagnosis of ocular toxoplasmosis.

Authors:  D O Ho-Yen; D J Chapman; D Ashburn
Journal:  Mol Pathol       Date:  2000-06

7.  Early aqueous humor analysis in patients with human ocular toxoplasmosis.

Authors:  J G Garweg; P Jacquier; M Boehnke
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Ocular toxoplasmosis after the fifth decade.

Authors:  Pierre Labalette; Laurence Delhaes; Fabrice Margaron; Bernard Fortier; Jean-François Rouland
Journal:  Am J Ophthalmol       Date:  2002-04       Impact factor: 5.258

9.  Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis.

Authors:  J G Montoya; J S Remington
Journal:  Clin Infect Dis       Date:  1996-08       Impact factor: 9.079

10.  Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

Authors:  J M Pinon; F Foudrinier; G Mougeot; C Marx; D Aubert; O Toupance; G Niel; M Danis; P Camerlynck; G Remy
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

View more
  10 in total

1.  Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis.

Authors:  A Fekkar; B Bodaghi; F Touafek; P Le Hoang; D Mazier; L Paris
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

2.  PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis.

Authors:  C Bourdin; A Busse; E Kouamou; F Touafek; B Bodaghi; P Le Hoang; D Mazier; L Paris; A Fekkar
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

3.  The antibody response in experimental ocular toxoplasmosis.

Authors:  Justus G Garweg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

Review 4.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 5.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

6.  Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis.

Authors:  H Talabani; M Asseraf; H Yera; E Delair; T Ancelle; P Thulliez; A P Brézin; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

7.  Diagnostic approach to ocular toxoplasmosis.

Authors:  Justus G Garweg; Jolanda D F de Groot-Mijnes; Jose G Montoya
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

8.  Seroepidemiology of Toxoplasma gondii infection in drivers involved in road traffic accidents in the metropolitan area of Guadalajara, Jalisco, Mexico.

Authors:  Ma de la Luz Galván-Ramírez; Laura Verónica Sánchez-Orozco; Laura Rocío Rodríguez; Saúl Rodríguez; Enrique Roig-Melo; Rogelio Troyo Sanromán; Erwin Chiquete; Juan Armendáriz-Borunda
Journal:  Parasit Vectors       Date:  2013-10-11       Impact factor: 3.876

9.  Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.

Authors:  Alejandra de-la-Torre; Arnaud Sauer; Alexander W Pfaff; Tristan Bourcier; Julie Brunet; Claude Speeg-Schatz; Laurent Ballonzoli; Odile Villard; Daniel Ajzenberg; Natarajan Sundar; Michael E Grigg; Jorge E Gomez-Marin; Ermanno Candolfi
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

Review 10.  Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.

Authors:  Dimitrios Kalogeropoulos; Hercules Sakkas; Bashar Mohammed; Georgios Vartholomatos; Konstantinos Malamos; Sreekanth Sreekantam; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-08-09       Impact factor: 2.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.